There is no commercial support for this activity.

About the speaker

Wayne Goodman, MD, D.C and Irene Ellwood Professor and Chair of the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine, specializes in Obsessive-Compulsive Disorder (OCD) and Deep Brain Stimulation (DBS) for intractable psychiatric illnesses. He is the principal developer of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), the gold standard for assessing OCD, and co-founder of the International OCD Foundation, the major advocacy group for patients with OCD. Prior to joining Baylor, he held senior administrative positions at Mount Sinai Hospital in NY, NIMH, and the University of Florida.  He graduated from Columbia University with a degree in Electrical Engineering, received his medical degree from Boston University School of Medicine and completed his internship, residency, and research fellowship at Yale School of Medicine where he remained on faculty for 7 years.  He was elected member of Association of American Physicians, Distinguished Life Fellow of the APA, and Fellow of the ACNP.  Dr. Goodman has received numerous awards and has published over 300 peer-reviewed articles with an h-index = 100. He is currently a Principal Investigator on grants from NIH’s BRAIN initiative including one on developing Adaptive DBS for OCD.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Wayne K. Goodman, MD, reports that he is a consultant for Biohaven. He will discuss DBS and TMS devices as well as off-label augmentation agents for OCD. He will not discuss any products or services during this presentation, except in their generic form. All relationships have been mitigated. This presentation will focus on research.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc., Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN,  Stacey Garnett, RN, MSN, Octavia Coit, MN, Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.